Recombinant Growth hormone response in Indian girls with Turner syndrome
<p>Turner syndrome (TS) is characterized by short statute and ovarian dysgenesis in females with one X chromosome and partial or complete absence of the second X. It has an estimated birth prevalence of 1/2000 to 1/5000 female live births [1]. There is a global growth delay in TS characterized...
Saved in:
Main Authors: | Inderpal Singh Kochar (Author), Smita Ramachandran (Author), Aashish Sethi (Author) |
---|---|
Format: | Book |
Published: |
International Journal of Clinical Endocrinology and Metabolism - Peertechz Publications,
2018-10-29.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recombinant human growth hormone in the treatment of Turner syndrome
by: Bessie E Spiliotis
Published: (2008) -
Response to three years of growth hormone therapy in girls with Turner syndrome
by: Hong Kyu Park, et al.
Published: (2013) -
Concomitant occurrence of Turner syndrome and growth hormone deficiency
by: Jung Yu, et al.
Published: (2016) -
Response of children with Turner syndrome with different types of karyotype abnormalities to growth hormone treatment
by: Jung Eun Choi, et al.
Published: (2024) -
Apparent mineralocorticoid excess: A case of hypertension in a child with delayed diagnosis leading to stroke
by: Inderpal Singh Kochar, et al.
Published: (2019)